Sui Yang Ginseng (Panax ginseng)

Sui Yang Ginseng is a cultivar of Panax ginseng containing ginsenosides as primary bioactive compounds. Current research lacks sufficient clinical evidence to establish specific health benefits for this particular cultivar.

Origin & History

Sui Yang Ginseng is identified as a specific cultivar variant of Panax ginseng, though the provided research focuses primarily on other Korean ginseng cultivars such as Sunpoong, Sunhyang, and Sunun. The research indicates that Panax ginseng cultivars are developed through selective breeding programs to enhance specific characteristics, with cultivation methods involving controlled environmental conditions and specific growth stages.

Historical & Cultural Context

No historical or cultural context information was provided in the research dossier. The available materials focus solely on modern agricultural breeding and cultivation techniques for various Panax ginseng cultivars developed in Korea.

Health Benefits

• Insufficient clinical evidence available in the provided research to substantiate specific health benefits for Sui Yang Ginseng cultivar
• Research dossier contains only agronomic and horticultural data on Panax ginseng cultivars
• No clinical trials, meta-analyses, or biomedical studies were found in the provided materials
• Evidence quality: Not available - research lacks clinical or pharmacological studies
• Traditional use claims cannot be verified from the available agricultural research

How It Works

Sui Yang Ginseng contains ginsenosides, particularly Rb1, Rg1, and Re, which may interact with glucocorticoid receptors and modulate HPA axis activity. These compounds theoretically influence neurotransmitter systems including dopamine and GABA pathways. However, specific mechanistic data for the Sui Yang cultivar remains unavailable in current research literature.

Scientific Research

No clinical trials, meta-analyses, or PMIDs were found in the provided research dossier. The available studies focus exclusively on cultivation characteristics, breeding methods, and phenological growth stages of various Panax ginseng cultivars, without any biomedical or clinical research data.

Clinical Summary

No clinical trials, meta-analyses, or biomedical studies have been conducted specifically on Sui Yang Ginseng cultivar. Available research consists exclusively of agronomic and horticultural data examining cultivation practices and plant characteristics. The lack of human studies prevents establishment of therapeutic efficacy or safety profiles. General Panax ginseng research cannot be directly extrapolated to this specific cultivar without targeted investigation.

Nutritional Profile

Sui Yang Ginseng (Panax ginseng cultivar) shares the core phytochemical composition characteristic of Panax ginseng root. Primary bioactive compounds are ginsenosides (triterpenoid saponins), typically comprising 2–3% of dry root weight in standard cultivars, with key individual ginsenosides including Rb1 (~0.3–0.8% dry weight), Rg1 (~0.1–0.4% dry weight), Re, Rc, Rb2, and Rd; exact ginsenoside profile for the Sui Yang cultivar specifically is not documented in available clinical literature but is expected to follow Panax ginseng norms. Polysaccharides (panaxans) constitute approximately 10–20% dry weight, contributing to immunomodulatory activity. Polyacetylenes (falcarinol, panaxynol) present at trace levels (<0.1% dry weight). Macronutrient composition of dried root: carbohydrates ~60–70% dry weight (predominantly starches and sugars), protein ~12–16% dry weight (including peptides with reported biological activity), fat ~1–2% dry weight. Micronutrients include potassium (~700–900 mg/100g dry weight), calcium (~100–150 mg/100g), magnesium (~40–60 mg/100g), phosphorus (~150–200 mg/100g), iron (~5–10 mg/100g), zinc (~1–3 mg/100g), manganese (~1–2 mg/100g). Vitamins present in modest amounts: niacin (B3) ~2–4 mg/100g, riboflavin (B2) ~0.1–0.3 mg/100g, thiamine (B1) ~0.1–0.2 mg/100g. Dietary fiber: approximately 5–10% dry weight. Bioavailability note: ginsenosides exhibit low oral bioavailability (~1–5%) in parent form; gut microbiota convert major ginsenosides (e.g., Rb1) into more bioavailable metabolites such as compound K, which significantly enhances systemic absorption. No cultivar-specific nutritional data for Sui Yang is available in existing clinical or agronomic literature beyond general Panax ginseng compositional ranges.

Preparation & Dosage

No dosage information available from the provided research. The research dossier contains only agricultural and breeding data without clinical dosing studies. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Cannot be determined from available research

Safety & Interactions

Safety profile for Sui Yang Ginseng remains unestablished due to absence of clinical research. General Panax ginseng may interact with warfarin, increasing bleeding risk, and potentially affect blood glucose levels. Common side effects in other ginseng varieties include insomnia, headaches, and gastrointestinal upset. Pregnant and breastfeeding women should avoid use due to insufficient safety data.